Nrc Health's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nrc Health's ROI in the third quarter of 2026?
Nrc Health achieved a return on average invested assets (ROI) of 6.54 % in its third quarter of 2026, which is below Nrc Health's average return on investment, which stands at 27.99%.

ROI has improved compared to 6% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 138 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 953 to 964.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Investment Change TTM	0.8 %	1.46 %	11.12 %	21.63 %	23.01 %
Y / Y Net Income Change TTM	-60.77 %	-67.45 %	-49.91 %	-5.3 %	187.69 %
Investment (TTM) in Millions	97	101	96	98	94
Return On Investment (TTM)	6.54 %	6 %	9.27 %	11.86 %	16.79 %
NRC's Overall Ranking	# 964	# 953	# 589	# 273	#
Seq. Investment Change TTM	0.94 %	-0.21 %	-0.34 %	0.4 %	1.61 %
Seq. Net Income Change TTM	9.97 %	-35.4 %	-22.11 %	-29.11 %	-8.73 %
Net Income (TTM) in Millions	6	6	9	12	16

NRC Company Profile >> Back to NRC Roi Comparisons >> See Annual NRC Return On Investment

Return On Investment NRC's Ranking
Within:	No.
Industry	# 8
Sector	# 139
Overall	# 964

Return On Investment Statistics
High	Average	Low
50.47 %	27.99 %	5.72 %
(Mar 31 2020)		(Jun 30 2026)

News about Nrc Health Return on Investment ROI

National Research Corporation Elevates Leadership Team to Drive Growth Opportunity

January 17, 2024

LINCOLN, Neb. - National Research Corporation, also known as NRC Health (NASDAQ: NRC), has recently made significant leadership changes by creating four executive officer positions. These developments come as the company aims to capitalize on growth opportunities in the market.
Helen Hrdy, an esteemed leader at NRC Health, has been promoted to the crucial role of Chief Customer Officer. This elevation signifies an expansion of her responsibilities within the organization. As the newly appointed Chief Customer Officer, Hrdy will play a pivotal role in strengthening customer relationships, establishing strategic alliances, and enhancing overall customer satisfaction.

Financial Statements
Nrc Health's III. Quarter Investments	$ 97 Millions	NRC's Balance sheet
Nrc Health's III. Quarter Income	$ 5 Millions	Quarterly NRC's Income Statement
NRC's Income by Division		See NRC's Income by Division

NRC Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	92	97	82	92	110
Y / Y Investment Growth	-4.56 %	17.77 %	-10.54 %	-16.69 %	16.59 %
Net Income in Millions	12	25	31	32	37
Y / Y Net Income Growth	-53.19 %	-19.98 %	-2.61 %	-15.12 %	0.55 %
Annual Return On Investment	12.57 %	25.63 %	37.73 %	34.65 %	34.01 %

Annual Roi Comment

In the fiscal year 2025 ROI decreased relative to the previous year to 12.57 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NRC's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NRC's Competitors
Subscribers only: Roi for Nrc Health's Suppliers
Subscribers only: Return On Investment for NRC's Customers

Other Ratios
NRC's Roa	NRC's Inventory Turnover Ratio	NRC's Growth Rates	NRC's Dividend Statistics
	NRC's Profitability Ratios	NRC's Asset Turnover Ratio	NRC's Dividend Growth
NRC's Roe	NRC's Valuation Ratios	NRC's Financial Strength Ratios	NRC's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector	ROI
Denali Therapeutics Inc	17.88 %
West Pharmaceutical Services Inc	17.65 %
Healthcare Services Group Inc	17.18 %
Neurocrine Biosciences Inc	16.94 %
Krystal Biotech Inc	16.91 %
Vertex Pharmaceuticals Inc	16.63 %
Intuitive Surgical Inc	16.30 %
Hca Healthcare Inc	15.54 %
Kiniksa Pharmaceuticals International Plc	15.45 %
Amgen Inc	13.64 %
Carlisle Companies Incorporated	13.64 %
Bristol myers Squibb Company	13.59 %
3m Company	13.24 %
Beone Medicines Ltd	13.17 %
Regeneron Pharmaceuticals Inc	13.00 %
Abbvie Inc	12.87 %
Lantheus Holdings Inc	11.96 %
Msa Safety Inc	11.78 %
Inspire Medical Systems inc	11.63 %
Transmedics Group Inc	11.55 %
Bioventus Inc	11.26 %
Tenet Healthcare Corp	10.91 %
Bio rad Laboratories Inc	10.59 %
Lemaitre Vascular Inc	10.56 %
Johnson and Johnson	10.53 %
Encompass Health Corporation	10.41 %
Ani Pharmaceuticals Inc	9.61 %
Tactile Systems Technology Inc	9.27 %
Boston Scientific Corporation	9.14 %
Brightspring Health Services Inc	9.01 %

Date modified: 2026-11-06T12:52:49+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.